Clinical Trial Update: A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 study of the new medicine NNC9733-0001 in healthy volunteers and participants with Type 2 diabetes is currently recruiting to assess safety and pharma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC9733-0001

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteer, Type 2 Diabetes | Phase 1 | Status: RECRUITING